Table 2. Clinical outcomes for the entire cohort.
Groups | Number | Median Survival (months) | 5 yr PFS* | 5 yr OS† | |
---|---|---|---|---|---|
Age (years) | 1-20 | 10 | 35 | 67% | 70% |
21-50 | 13 | 26 | 44% | 51% | |
>50 | 15 | 17 | 33% | 55% | |
Chloroma Diagnosis | At initial presentation | 18 | 61 | 67% | 73% |
After systemic disease | 20 | 14 | 27% | 31% | |
Site | Head & Neck | 14 | 17 | ||
Extremity | 7 | 17 | |||
Abdomen | 5 | 62 | |||
Spine | 5 | 7 | |||
Pelvis | 2 | 40 | |||
Chest wall/Mediastinum | 3 | 21 | |||
Genitourinary | 4 | 109 |
Abbreviations:
= progression free survival;
= overall survival.